Press Release

Nucleic Acid Amplification Testing Market to Grow with a CAGR of 11.56% through 2030

Rising Demand for Rapid and Accurate Diagnostics and Advancements in Biotechnology are expected to drive the Global Nucleic Acid Amplification Testing Market growth in the forecast period, 2026-2030

 

According to TechSci Research report, “Nucleic Acid Amplification Testing Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030F”, the Global Nucleic Acid Amplification Testing Market stood at USD 8.08 billion in 2024 and is anticipated to grow with a CAGR of 11.56% in the forecast period, 2026-2030.

The COVID-19 pandemic has significantly influenced the nucleic acid amplification testing (NAAT) market, driving unprecedented demand for rapid and accurate diagnostic solutions. The urgency to detect the SARS-CoV-2 virus effectively has accelerated the adoption of NAAT technologies and underscored the critical importance of investing in advanced diagnostic capabilities. This surge has been further fueled by the introduction of innovative NAAT products, such as isothermal amplification technologies, designed to meet the growing need for point-of-care and high-throughput testing.

NAAT technologies are also gaining prominence in biobanking and genomics research, supporting the storage and analysis of genetic materials. As the fields of genetics and genomics continue to expand, NAAT plays a pivotal role in enabling advanced research initiatives. Moreover, the rising prevalence of RNA-based viruses, including SARS-CoV-2, has heightened the demand for RNA-specific diagnostic solutions. This trend is anticipated to drive innovation and adoption of RNA-targeted NAAT techniques, enhancing the market’s growth trajectory.

Global demand for NAAT is also propelled by the increasing prevalence of infectious diseases and the urgent need for precise diagnostic tools to manage outbreaks effectively. The emergence of pathogens such as the Monkeypox virus has created new growth opportunities, with several NAAT products receiving regulatory approvals to address these challenges. NAAT’s precise detection capabilities extend beyond infectious diseases, finding applications in oncology, personalized medicine, and forensic science, which further diversify its market potential.

Despite its advantages, NAAT technologies like polymerase chain reaction (PCR) face challenges that may limit adoption, particularly in point-of-care settings. PCR’s reliance on thermal cycling and sophisticated temperature control equipment poses logistical barriers, potentially slowing the growth of PCR-based solutions. Addressing these limitations will be critical to unlocking the full potential of NAAT in decentralized diagnostic environments and sustaining the market’s long-term expansion.

           

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Nucleic Acid Amplification Testing Market

 

The Global Nucleic Acid Amplification Testing Market is segmented into type, application, end user, regional distribution, and company.

Based on end use, the central and reference laboratories category took the lead in terms of revenue share in 2024, primarily because of its broad range of testing services and its coverage across various healthcare settings. Additionally, government support in the form of initiatives is facilitating the expansion of testing capabilities for these laboratories. during the forecast period from 2026 to 2030, the hospital sector is projected to experience the most rapid Compound Annual Growth Rate (CAGR). This growth is driven by the increasing global healthcare expenditure and the growing significance of nucleic acid amplification techniques in disease surveillance and the prevention of outbreaks. Similarly, the expansion of hospital testing capabilities following the COVID-19 pandemic and the availability of high-throughput testing technologies have the potential to significantly enhance market prospects for nucleic acid amplification testing.

 

Major companies operating in Global Nucleic Acid Amplification Testing Market are:

·         F Hoffmann-La Roche AG

·         Becton, Dickinson and Company

·         Danaher Corporation

·         Abbott Laboratories Inc

·         Illumina Inc

·         Siemens Healthineers AG

·         bioMérieux SA

·         Novartis AG

·         Bio-Rad Laboratories Inc

·         Seegene Inc 

 

Download Free Sample Report

Customers can also request for 10% free customization on this report

 

“The Global Nucleic Acid Amplification Testing Market is poised for continued growth and innovation. The integration of digital technologies into NAAT is another significant trend. Digital PCR and next-generation sequencing (NGS) are becoming more prevalent due to their ability to provide high sensitivity, precision, and the ability to perform multiplexed assays. These technologies are transforming the way nucleic acid testing is conducted, enabling more detailed genetic analysis and more accurate detection of low-abundance targets. Additionally, the use of digital platforms for data analysis and interpretation is improving the efficiency and reliability of NAAT, making these tests more accessible and user-friendly.,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

Nucleic Acid Amplification Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Polymerase Chain Reaction (PCR) tests, Isothermal Nucleic Acid Amplification Technology (INAAT) tests, Ligase Chain Reaction (LCR) tests), By Application (Infectious disease testing, Oncology testing, Genetic & mitochondrial disease testing, Others), By End User (Hospitals, Central and reference laboratories, Others), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of Global Nucleic Acid Amplification Testing Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Nucleic Acid Amplification Testing Market.

 

Contact

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: sales@techsciresearch.com

Website: www.techsciresearch.com

Relevant News